Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis
Open Access
- 1 November 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in HIV and AIDS
- Vol. 5 (6), 504-510
- https://doi.org/10.1097/coh.0b013e32833ed774
Abstract
Purpose of review Immune reconstitution inflammatory syndrome (IRIS) is the paradoxical worsening or unmasking of an infection or neoplasm in HIV-1-infected patients shortly after antiretroviral therapy (ART) initiation. New insights into the pathogenesis of IRIS may help identify biomarkers that could be useful in predicting or diagnosing IRIS. Recent findings Studies of immunopathogenesis have shown a signification activation of both innate and adaptive immune responses with elevation of plasma or serum chemokines and cytokines. Markers of inflammation such as C-reactive protein, interferon-inducible protein 10 or interferon γ may be helpful as predictors of IRIS events. In addition, tuberculosis (TB)-associated IRIS is associated with a prominent Th1 response that can be heightened even prior to ART initiation in cases of unmasking TB, and may assist in early diagnosis. Large prospective studies are needed to elucidate the predictive and diagnostic value of IRIS biomarkers and advance them to the clinic. Summary Reversal of immunosuppression by ART leads to exaggerated pathogen-specific immune responses (known as IRIS) that appear to be primed prior to therapy. Inflammatory markers, chemokines and cytokines that signify innate and adaptive immune activation are biomarkers that could prove of clinical value after appropriate validation.Keywords
This publication has 44 references indexed in Scilit:
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 casesThe Lancet Neurology, 2010
- Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infectionNature Medicine, 2010
- Immunopathogenesis and Diagnosis of Tuberculosis and Tuberculosis‐Associated Immune Reconstitution Inflammatory Syndrome during Early Antiretroviral TherapyThe Journal of Infectious Diseases, 2009
- Progressive Multifocal Leukoencephalopathy after Natalizumab MonotherapyNew England Journal of Medicine, 2009
- Generation and maintenance of memory CD4+ T CellsCurrent Opinion in Immunology, 2009
- Homeostasis of Naive and Memory T CellsImmunity, 2008
- Type 1 Helper T Cells and FoxP3-positive T Cells in HIV–Tuberculosis-associated Immune Reconstitution Inflammatory SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2008
- IL-18 Bridges Innate and Adaptive Immunity through IFN-γ and the CD134 PathwayThe Journal of Immunology, 2006
- Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patientsAIDS, 2006
- Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patientsAIDS, 1999